|
 |
| home > pmps > winter 2002 > the financial and operational benefits of e-learning in regulatory compliance |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
We believe that e-learning will increasingly be employed by pharmaceutical organisations to achieve and maintain compliance training as mandated by the regulatory authorities. e-Learning not only enhances compliance initiatives but also delivers the benefits of improved operational efficiency and higher profitability. Given the global nature of today's pharmaceutical operations, as well as an increased regulatory burden, e-learning has found a niche in the pharmaceutical manufacturing process, and ties in well with new FDA technology initiatives.
It has been well documented that e-learning cuts down the learning curve and delivers significant cost savings associated with traditional instructor led training (ILT). Furthermore, its interactive nature improves employee (student) material retention rates, and offers companies with customised solutions to their training needs. Since e-learning and computer-based training (CBT) integrates and complements traditional classroom-based training programmes, companies could achieve higher employee productivity by adopting a blended approach to learning.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Global Clinical Outsourcing Partnerships
26-27 March 2009, Mariott Hotel, Brussels
This Jacob Fleming event is designed to promote direct business. It features a two-day educational session with case studies, presentations and interactive sessions. This forum offers networking and the forging of new business partnerships in a unique business-driven environment.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
|
